Search - tctmd.com

Displaying 921 - 940 of 1231

Sort: Relevancy | Date

News Industry News

Extended Follow-Up of Multicenter Trial Demonstrates Continued Superiority of Bivalirudin to Heparin with and without Glycoprotein IIB, IIIA Inhibition in Patients with Acute Myocardial Infarction

September 15, 2014

Presentation TCT 2014

Atrial Fibrillation: Stratifying Stroke Risk and Determining Anticoagulant Therapy

Presenter: Hilary Nierenberg, Julie Logan, Asma Hussaini

September 14, 2014

Presentation TCT 2014

Position Statement: Heparin Will Once Again Become the Anticoagulant of Choice for PCI in Stable and Unstable Coronary Syndromes

Presenter: Kishore J. Harjai, Michael S. Lee

September 14, 2014

News Conference News TCT 2014

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

September 14, 2014

News Conference News TCT 2014

EUROMAX Substudy: Bivalirudin Noninferior to Heparin Plus GPI for Myocardial Reperfusion

September 14, 2014

Presentation TCT 2014

Role of New Oral Anticoagulants and New ADP Antagonists in ACS Patients

Presenter: Roxana Mehran, Mohamed Sobhy

September 13, 2014

News Conference News TCT 2014

Meta-analysis: Less Bleeding, More Stent Thrombosis with Bivalirudin vs. Heparin After PCI

September 13, 2014

News Conference News ESC 2014

ACCOAST Substudy: Prasugrel Pretreatment Linked With Increased Bleeding in NSTEMI Patients

Yael L. Maxwell

September 03, 2014

News Industry News

Subgroup Analysis of ENGAGE AF-TIMI 48 Explores the Relationship Between Edoxaban Dose, Concentration, Anti-Factor Xa Activity and Outcomes

September 02, 2014

News Daily News

HORIZONS-AMI Substudy: Anticoagulation After Primary PCI Yields Worse Outcomes

September 02, 2014

News Daily News

With Some Caveats, SAFE-PCI Shows Positive Signs for Radial Access in Women

Yael L. Maxwell

September 02, 2014

News Daily News

Subestudio del HORIZONS-AMI: La Anticoagulación Primaria Post-PCI Da Peores Resultados

September 02, 2014

News Conference News ESC 2014

ATLANTIC: Prehospital Ticagrelor Safe in STEMI, But No Added Benefit Compared With In-Hospital Administration

Yael L. Maxwell

September 01, 2014

News Conference News ESC 2014

Post-Acute MI Survival Improving for Elderly Patients in France

Todd Neale

August 30, 2014

News Daily News

Meta-Analysis: Worse Clinical Outcomes But Less Bleeding With Bivalirudin in PCI

Todd Neale

August 20, 2014

News Daily News

Meta-analysis: Value of PFO Closure vs Medical Therapy Varies by Device

Caitlin E. Cox

August 20, 2014

News Daily News

Meta Análisis: El Valor del Cierre del FOP frente al Tratamiento Médico Depende del Dispositivo

Caitlin E. Cox

August 20, 2014

News Daily News

La Mayoría de Pacientes de EE.UU. siguen recibiendo el Alta Hospitalaria con Dosis Altas de Aspirina tras Sufrir un IAM

Todd Neale

August 20, 2014

News Daily News

Study Indicates Snare Device for LAA Closure Should Only Be Used in Highest-Risk Patients

Yael L. Maxwell

August 07, 2014

News Daily News

Según Estudio un Dispositivo Cepo para el Cierre del AAI Solo debería de Usarse en los Pacientes de Más Alto Riesgo

Yael L. Maxwell

August 07, 2014

Advertisement

Extended Follow-Up of Multicenter Trial Demonstrates Continued Superiority of Bivalirudin to Heparin with and without Glycoprotein IIB, IIIA Inhibition in Patients with Acute Myocardial Infarction

Atrial Fibrillation: Stratifying Stroke Risk and Determining Anticoagulant Therapy

Position Statement: Heparin Will Once Again Become the Anticoagulant of Choice for PCI in Stable and Unstable Coronary Syndromes

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

EUROMAX Substudy: Bivalirudin Noninferior to Heparin Plus GPI for Myocardial Reperfusion

Role of New Oral Anticoagulants and New ADP Antagonists in ACS Patients

Meta-analysis: Less Bleeding, More Stent Thrombosis with Bivalirudin vs. Heparin After PCI

ACCOAST Substudy: Prasugrel Pretreatment Linked With Increased Bleeding in NSTEMI Patients

Subgroup Analysis of ENGAGE AF-TIMI 48 Explores the Relationship Between Edoxaban Dose, Concentration, Anti-Factor Xa Activity and Outcomes

HORIZONS-AMI Substudy: Anticoagulation After Primary PCI Yields Worse Outcomes

With Some Caveats, SAFE-PCI Shows Positive Signs for Radial Access in Women

Subestudio del HORIZONS-AMI: La Anticoagulación Primaria Post-PCI Da Peores Resultados

ATLANTIC: Prehospital Ticagrelor Safe in STEMI, But No Added Benefit Compared With In-Hospital Administration

Post-Acute MI Survival Improving for Elderly Patients in France

Meta-Analysis: Worse Clinical Outcomes But Less Bleeding With Bivalirudin in PCI

Meta-analysis: Value of PFO Closure vs Medical Therapy Varies by Device

Meta Análisis: El Valor del Cierre del FOP frente al Tratamiento Médico Depende del Dispositivo

La Mayoría de Pacientes de EE.UU. siguen recibiendo el Alta Hospitalaria con Dosis Altas de Aspirina tras Sufrir un IAM

Study Indicates Snare Device for LAA Closure Should Only Be Used in Highest-Risk Patients

Según Estudio un Dispositivo Cepo para el Cierre del AAI Solo debería de Usarse en los Pacientes de Más Alto Riesgo

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content